Skip to content
Search

Latest Stories

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.


New data from the House of Commons Library reveals that the number of pharmacies across England and Wales has fallen by 8%, dropping from 12,204 in September 2016 to just 11,184 by January 2025.

The analysis found that 77% of the 440 constituencies across England and Wales have experienced a decline in pharmacy numbers over the past decade. Some areas have been hit particularly hard — with Feltham and Heston, Bristol East, and Newbury each losing around a third of their pharmacies.

The Liberal Democrats, who commissioned the research, warned that "pharmacy deserts" are becoming "normalised" and urged the government to introduce urgent support measures, including tax relief for pharmacies.

“The government recognises that pharmacies play a vital role in our healthcare system,” said Kinnock.

“We are committed to expanding the role of pharmacies and better utilising the skills of pharmacists and pharmacy technicians.”

“Employers clearly have a key role in retaining staff and making jobs in community pharmacy attractive.”

“To support employers, NHS England has provided a number of fully funded national training opportunities for pharmacists and pharmacy technicians to help support private contractors to deliver quality National Health Services, including Pharmacy First.”

He also confirmed that the government has concluded its consultation on funding for 2024/25 and 2025/26, reaching an agreement with Community Pharmacy England to increase the community pharmacy contractual framework to £3.073 billion.

“This deal represents the largest uplift in funding of any part of the NHS, over 19% across 2024/25 and 2025/26,” Kinnock added.

“This shows a commitment to rebuilding the sector.”

The National Pharmacy Association (NPA) has welcomed the new funding deal as a “clear step forward,” but warned that it still leaves pharmacies facing a £2.5 billion shortfall, as highlighted by an NHS-commissioned independent economic analysis.

The NPA has long cautioned about the growing risk of “pharmacy deserts,” with patients in rural and isolated areas increasingly struggling to access vital services from their local pharmacies.

The latest data from the NHS Business Services Authority (NHSBSA) also shows that the number of bricks-and-mortar community pharmacies in England has fallen below 10,000 for the first time in 20 years.

As of the end of March 2025, there were 9,999 community pharmacies (excluding distance-selling pharmacies) operating in England — down from 10,837 at the start of 2021. This represents a net loss of 838 pharmacies over four years.

Between January 2024 and March 2025 alone, England saw 274 pharmacy closures — an average of more than five closures per week.

The most recent Workforce Wellbeing Survey, conducted by the Royal Pharmaceutical Society (RPS) in partnership Pharmacist Support, revealed that 87% of pharmacy professionals were at high risk of burnout, with nearly half of the workforce negatively impacted by financial pressures.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less